Given the incomplete response of TNF blockade to treat depression14, interleukin (IL)-6 blockade may be an effective strategy15,16 since IL-6 is reliably elevated in MDD17–22 and associated with induction of depression following inflammatory challenge13,14. The gene discussed is IL6; the disease is major depressive disorder.